fbpx

Health Care

Johnson Johnson to share clinical trial data

The New Brunswick-based pharmaceutical giant, via its Janssen Research and Development LLC subsidiary, will collaborate with Yale School of Medicine’s Open Data Access on the project. The agreement means physicians and investigators seeking clinical trial data from Johnson and Johnson’s drugs can do so by requesting access to YODA. The Yale group will review requests ...

Read More »

Derma Sciences closes 86M offering

According to the announcement, the underwritten public offering of 7.5 million shares, including the exercise of the underwriters’ option, resulted in total net proceeds to the Company were approximately $80.7 million after deducting the underwriting discount and estimated offering expenses.The company first announced the offering last week.RELATED: Princeton Derma Science hiring to support product launches ...

Read More »

MYOS Corp. closes 4.735M private equity financing

The fund will help support research and development in therapeutic solutions for treatment of muscle loss associated with aging and other chronic illnesses. The investors in the private placement acquired approximately 31.56 million units of the company’s stock at 15 cents per unit, the announcement said.

Read More »

Pharmaceutical companies lag in embracing social media

The IMS Institute for HealthCare Informatics, a Parsippany-based provider of health care data, said of the top 50 pharmaceutical companies globally, nearly half actively participate in social media while only 10 use all three social networking services — Facebook, Twitter and YouTube — for health care topics.Among companies actively participating in social media, IMS ranked ...

Read More »

Derma Sciences announces public offering worth up to $86M

According to the announcement, the company has granted the underwriters a 30-day option to purchase an additional 978,261 shares to cover any potential over-allotments, if any. The offering is expected to close Tuesday. Piper Jaffray & Co. and Canaccord Genuity Inc. are acting as joint bookrunning managers for the offering. Oppenheimer & Co. Inc. and ...

Read More »

PTC Therapeutics names chief medical officer

According to the announcement, Spiegel has been filling the CMO role since 2011, when he took the position on a part-time consulting basis. Prior to his work at PTC, Spiegel was chief medical officer at Schering-Plough.Additional management changes are detailed in the release.  Submit a nomination for General Counsel of the Year >

Read More »

Citing patent expiration, Novartis to lay off 222 New Jerseyans

The closure, reported Wednesday by the Star-Ledger, results from the Switzerland-based pharmaceutical company’s loss of the patent for Diovan, a blood pressure medication. The patent expired in 2012 and the rise of generic alternatives has pushed demand below the minimum required to continue operations at the Suffern plant. The closure will occur during the next ...

Read More »

Protalex completes $2.8M private placement

According to the announcement, the placement accredited investors in the form of 471,334 shares of common stock at $6 per share. Proceeds of the financing will be used for working capital purposes, principally to fund ongoing clinical trials and studies and related activities. Like NJBIZ on Facebook: facebook.com/NJBIZStay informed with free NJBIZ email newsletters >

Read More »